Zhang Ting-ting, Liu Dong, Calabro Samuele, Eisenbarth Stephanie C, Cattoretti Giorgio, Haberman Ann M
Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, United States of America.
Department of Pathology, University of Milano-Bicocca, Monza (MB), Italy.
PLoS One. 2014 Jun 30;9(6):e101208. doi: 10.1371/journal.pone.0101208. eCollection 2014.
The transcriptional repressor BCL6 plays an essential role in the development of germinal center B cells and follicular helper T cells. However, much less is known about the expression and function of BCL6 in other cell types. Here we report that during murine dendritic cell (DC) ontogeny in vivo, BCL6 is not expressed in bone marrow hematopoietic stem cells, common DC precursors and committed precursors of conventional DCs (pre-cDCs), but is elevated in peripheral pre-cDCs. BCL6 protein levels rise as pre-cDCs differentiate into cDCs in secondary lymphoid organs. Elevated protein levels of Bcl6 are observed in all cDC subsets, with CD8α+ cDCs displaying the greatest levels. Co-staining of Ki-67 revealed BCL6hi cDCs to be more proliferative than BCL6lo cDCs. After adjuvant inoculation, BCL6 levels are significantly reduced in the CD11cint MHC class IIhi CD86hi cDCs. Activation-induced BCL6 reduction correlated with reduced proliferation. A LPS injection study further confirmed that, in response to microbial stimuli, BCL6 levels are dynamically regulated during the maturation of CD11cint MHC class IIhi splenic cDCs. This reduction of BCL6 levels in cDCs does not occur after LPS injection in MyD88-/- TRIF-/- mice. Thus, regulation of Bcl6 protein levels is dynamic in murine cDCs during development, maturation and activation in vivo.
转录抑制因子BCL6在生发中心B细胞和滤泡辅助性T细胞的发育中起关键作用。然而,关于BCL6在其他细胞类型中的表达和功能却知之甚少。在此我们报告,在小鼠体内树突状细胞(DC)的个体发育过程中,BCL6在骨髓造血干细胞、普通DC前体以及常规DC(pre-cDC)的定向前体中均不表达,但在外周pre-cDC中表达升高。随着pre-cDC在二级淋巴器官中分化为cDC,BCL6蛋白水平升高。在所有cDC亚群中均观察到Bcl6蛋白水平升高,其中CD8α+cDC的水平最高。Ki-67共染色显示,BCL6高表达的cDC比BCL6低表达的cDC增殖能力更强。佐剂接种后,CD11cintMHC II类hi CD86hi cDC中的BCL6水平显著降低。激活诱导的BCL6降低与增殖减少相关。LPS注射研究进一步证实,在对微生物刺激作出反应时,CD11cintMHC II类hi脾cDC成熟过程中BCL6水平受到动态调节。在MyD88-/-TRIF-/-小鼠中注射LPS后,cDC中BCL6水平并未降低。因此,在体内发育、成熟和激活过程中,小鼠cDC中Bcl6蛋白水平的调节是动态的。